294 related articles for article (PubMed ID: 32306751)
1. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
Jogalekar MP; Veerabathini A; Gangadaran P
Exp Biol Med (Maywood); 2020 Jun; 245(11):964-969. PubMed ID: 32306751
[TBL] [Abstract][Full Text] [Related]
2. Understanding of COVID-19 based on current evidence.
Sun P; Lu X; Xu C; Sun W; Pan B
J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
[TBL] [Abstract][Full Text] [Related]
3. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Li G; De Clercq E
Nat Rev Drug Discov; 2020 Mar; 19(3):149-150. PubMed ID: 32127666
[No Abstract] [Full Text] [Related]
5. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
Banerjee AK; Arora N
Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
[No Abstract] [Full Text] [Related]
6. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Li H; Liu Z; Ge J
J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
[TBL] [Abstract][Full Text] [Related]
7. COVID-2019: update on epidemiology, disease spread and management.
Sahu KK; Mishra AK; Lal A
Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723
[TBL] [Abstract][Full Text] [Related]
8. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
9. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
[No Abstract] [Full Text] [Related]
10. [Remdesivir, the antiviral hope against SARS-CoV-2].
Reina J
Rev Esp Quimioter; 2020 Jun; 33(3):176-179. PubMed ID: 32239125
[TBL] [Abstract][Full Text] [Related]
11. The race against COVID-19.
Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
[No Abstract] [Full Text] [Related]
12. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
13. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G
Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029
[No Abstract] [Full Text] [Related]
14. Rapid review for the anti-coronavirus effect of remdesivir.
Li Z; Wang X; Cao D; Sun R; Li C; Li G
Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
[TBL] [Abstract][Full Text] [Related]
15. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
16. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
Wang Y; Wang Y; Chen Y; Qin Q
J Med Virol; 2020 Jun; 92(6):568-576. PubMed ID: 32134116
[TBL] [Abstract][Full Text] [Related]
17. Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.
Fadaka AO; Sibuyi NRS; Adewale OB; Bakare OO; Akanbi MO; Klein A; Madiehe AM; Meyer M
J Int Med Res; 2020 Aug; 48(8):300060520949077. PubMed ID: 32842818
[TBL] [Abstract][Full Text] [Related]
18. An update on novel COVID-19 pandemic: a battle between humans and virus.
Prajapati S; Sharma M; Kumar A; Gupta P; Narasimha Kumar GV
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5819-5829. PubMed ID: 32495921
[TBL] [Abstract][Full Text] [Related]
19. When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy.
Kiessling L; MacLaughlin C; Sattin S
ACS Chem Biol; 2020 Jun; 15(6):1279-1281. PubMed ID: 32383582
[No Abstract] [Full Text] [Related]
20. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
Yashavantha Rao HC; Jayabaskaran C
J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]